Pain Therapeutics Can't Duck Investors' Remoxy Suit
A Texas federal judge refused Tuesday to derail a putative class action accusing Pain Therapeutics Inc. of misleading investors about the prospects for painkiller Remoxy, saying there was plausible evidence executives...To view the full article, register now.
Already a subscriber? Click here to view full article